Abhinav Shashank, Innovaccer CEO
January 23, 2025 10:05 AM EST
Health Tech

With $275M in fresh fund­ing, In­no­vac­cer's look­ing to make more health tech deals

Ngai Yeung

Health Tech Reporter

In­no­vac­cer is buy­ing up health tech com­pa­nies with the goal of pro­vid­ing health­care or­ga­ni­za­tions with a sim­ple place to go for a num­ber of tools …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

The cru­cial obe­si­ty da­ta to watch for this year

No­vo Nordisk’s amy­cretin prompts 22% weight loss in ear­ly obe­si­ty tri­al

Obe­si­ty biotech Aard­vark files for IPO to ad­vance oral, hunger-sup­press­ing drug

Mod­er­na in­for­ma­tion chief to re­tire next month; Pharm­ing looks to Flag­ship for first new CEO since 2008

Boehringer merges can­cer vac­cine and on­colyt­ic virus teams; Dan­tari sells off as­sets

sponsored

Fu­el­ing More Break­throughs: Man­u­fac­tur­ing In­no­va­tion to Ex­pand Gene Ther­a­py’s Reach

A service from the Financial Times